Macrophage Marker is fastest growing segment fueling the growth of Macrophage Marker Market
The global Macrophage Marker Market is estimated to be valued at US$ 256.2 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Macrophage markers are cellular proteins that identify macrophages and are used to analyze their phenotype and function. They play a vital role in inflammatory and immune responses.
Market key trends:
The increasing application of macrophage markers in stem cell research and development due to their role in modulating stem cell behavior is one of the key trends driving the growth of the macrophage marker market. Macrophages secrete various signaling molecules that help regulate stem cell differentiation, proliferation, and migration. Macrophage markers aid in understanding the complex macrophage-stem cell interactions and developing stem cell-based therapies.
Segment Analysis
The global macrophage marker market is segmented on the basis of product, application, end user and region. Based on product, the macrophage marker market is segmented into antibodies, ELISA kits, flow cytometry antibodies and other products. The antibody sub-segment dominates the overall market as they are extensively used for various immune-based research including immunoprecipitation, western blotting and histochemistry.
Key Takeaways
The Global Macrophage Marker Market Size is expected to witness high growth, exhibiting a CAGR of 6.5% over the forecast period, due to increasing research on immunology-based diseases. The market size for macrophage marker was valued at US$ 256.2 Mn in 2023 and is anticipated to reach US$ 402.6 Mn by 2030.
Regionally, North America dominated the global market and accounted for over 35% of the total revenue in 2023 due to strong research funding and advanced healthcare infrastructure in the US and Canada. The Asia Pacific macrophage marker market is the fastest growing region at a CAGR of 7.5% owing to expanding biomedical sciences research in China, India, and other Asian countries. Japan, South Korea, and Australia are also major regional markets.
Key players operating in the macrophage marker market are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., and MBL International Corporation.
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian